Skip to content

Clinical trials

Observational Hepatitis B trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B Phase: Observational Country / region: Canada Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20051
20102
20111
20121
20131
20143
20151
20161
20181

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Unknown status3
Active, not recruiting2
Terminated2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Health Network, Toronto3
University of Pennsylvania2
University of Pittsburgh2
Beckman Coulter, Inc.1
Centre hospitalier de l'Université de Montréal (CHUM)1
Gilead Sciences1
Target PharmaSolutions, Inc.1
University of Arkansas1
University of Calgary1
Virginia Commonwealth University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B14
Hepatitis C4
Hepatitis2
Non-alcoholic Fatty Liver Disease2
Acquired Immunodeficiency Syndrome1
Autoimmune Diseases1
Carcinoma, Hepatocellular1
Cholangitis, Sclerosing1
Fibrosis1
Hepatitis B, Chronic1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.